A clinical roadmap for implementing the treat-to-target strategy in RA, emphasizing early aggressive intervention and regular DAS28 assessments to achieve and maintain clinical remission.

Detailed safety profiles and monitoring requirements for conventional synthetic DMARDs, including methotrexate and hydroxychloroquine, tailored to the specific healthcare context of West Africa.

A practical toolkit for performing rapid joint counts and functional assessments in a busy clinical setting, helping clinicians track objective progress and adjust therapy.

An overview of the indications and screening protocols for biologic therapy in RA, including TB screening and cost-effective prescribing considerations for the regional context.